Login / Signup

A review of the development of gangrene in patients with systemic lupus erythematosus - A 44-year follow-up study.

Joana RuaDavid Alan Isenberg
Published in: Lupus (2023)
Although rare, gangrene is a sinister, potentially late developing complication of SLE, it rarely recurs. It is associated with anti-phospholipid antibodies, active disease, and other possible triggers such as infection and cancer. Anticoagulation therapy, steroids and iloprost, and further immunosuppression may be needed to stop the evolution of gangrene.
Keyphrases
  • papillary thyroid
  • systemic lupus erythematosus
  • atrial fibrillation
  • venous thromboembolism
  • squamous cell
  • stem cells
  • squamous cell carcinoma
  • lymph node metastasis
  • young adults